CN1954812A - 依达拉奉的新用途 - Google Patents
依达拉奉的新用途 Download PDFInfo
- Publication number
- CN1954812A CN1954812A CN 200510095061 CN200510095061A CN1954812A CN 1954812 A CN1954812 A CN 1954812A CN 200510095061 CN200510095061 CN 200510095061 CN 200510095061 A CN200510095061 A CN 200510095061A CN 1954812 A CN1954812 A CN 1954812A
- Authority
- CN
- China
- Prior art keywords
- sepsis
- edaravone
- shock
- group
- rats
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
组别 | 剂量(mg/kg) | n | 死亡率 |
模型组6mg/kg依达拉奉3mg/kg依达拉奉1.5mg/kg依达拉奉XigrisTM组 | -631.558.34 | 1610101010 | 13/161/10**1/10**3/10*0/10** |
指标 | 组别 | n | 正常值 | LPS注射后时间(h) | |||
0 | 2 | 4 | 6 | ||||
LVESP(mmHg) | 假手术组模型组6mg/kg依达拉奉3mg/kg依达拉奉1.5mg/kg依达拉奉XigrisTM组 | 101010101010 | 161.22±12.63155.52±9.69159.44±9.84160.46±13.69161.11±8.26158.06±17.07 | 161.22±12.63148.58±11.40150.50±11.57150.37±15.08154.84±9.31143.07±14.79▲ | 146.53±21.68138.60±16.10141.97±16.67133.58±16.46148.09±16.64138.12±19.53 | 143.41±11.65105.26±10.55▲▲131.61±10.18**128.94±9.39**141.50±9.78**144.81±14.86** | 132.84±22.5890.21±8.46▲▲128.70±16.32**119.41±18.14**132.44±9.62**131.49±18.72** |
组别 | N | SOD(U/ml) | MDA(nmol/ml) | CAT(U/ml) |
假手术组模型组6mg/kg依达拉奉3mg/kg依达拉奉1.5mg/kg依达拉奉XigrisTM组 | 1091010108 | 45.58±5.2521.53±1.48▲▲49.54±3.56**41.14±3.51**35.22±2.81*40.21±4.51** | 5.78±0.0414.68±1.08▲4.39±0.12**5.32±1.80*6.44±0.31*10.88±1.52 | 32.34±2.5411.46±2.46▲34.16±2.15**34.59±2.94**33.89±3.62**31.65±2.52** |
组别 | N | LD(mmol/L) | LDH(U/L) | UN(mg/L) | Cr(μmol/L) |
假手术组模型组6mg/kg依达拉奉3mg/kg依达拉奉1.5mg/kg依达拉奉XigrisTM组 | 1091010108 | 1.30±0.364.87±0.03▲▲1.55±0.02**1.60±0.521.92±0.583.94±0.46 | 4679.19±171.074990.31±496.774048.62±192.084290.77±365.274621.54±217.864744.65±361.16 | 140.38±13.5728281.73±24.7080▲▲136.85±17.795**177.52±13.952*228.31±32.09172.69±12.68* | 46.59±7.5073.51±8.5635.82±2.17**38.50±4.46**45.47±4.8739.39±13.68* |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510095061 CN1954812B (zh) | 2005-10-28 | 2005-10-28 | 依达拉奉的新用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510095061 CN1954812B (zh) | 2005-10-28 | 2005-10-28 | 依达拉奉的新用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1954812A true CN1954812A (zh) | 2007-05-02 |
CN1954812B CN1954812B (zh) | 2010-05-05 |
Family
ID=38062486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200510095061 Active CN1954812B (zh) | 2005-10-28 | 2005-10-28 | 依达拉奉的新用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1954812B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101933899A (zh) * | 2010-08-26 | 2011-01-05 | 南京先声东元制药有限公司 | 一种依达拉奉注射液及其制备方法 |
CN102349893A (zh) * | 2011-08-19 | 2012-02-15 | 福建天泉药业股份有限公司 | 依达拉奉药物组合物 |
CN104055758A (zh) * | 2013-03-18 | 2014-09-24 | 江苏先声药物研究有限公司 | 一种药物组合物及其在制备治疗烫伤药物中的用途 |
WO2015051695A1 (zh) * | 2013-10-12 | 2015-04-16 | 烟台益诺依生物医药科技有限公司 | 一种药物组合物在制备治疗脓毒症和炎性肺损伤药物中的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1440749A (zh) * | 2003-03-24 | 2003-09-10 | 南昌弘益科技有限公司 | 易达拉封注射剂及其制备工艺——治疗急性脑梗塞 |
CN1241565C (zh) * | 2003-04-16 | 2006-02-15 | 浙江震元制药有限公司 | 依达拉奉药物组合物及制备 |
-
2005
- 2005-10-28 CN CN 200510095061 patent/CN1954812B/zh active Active
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101933899A (zh) * | 2010-08-26 | 2011-01-05 | 南京先声东元制药有限公司 | 一种依达拉奉注射液及其制备方法 |
CN102349893A (zh) * | 2011-08-19 | 2012-02-15 | 福建天泉药业股份有限公司 | 依达拉奉药物组合物 |
CN104055758A (zh) * | 2013-03-18 | 2014-09-24 | 江苏先声药物研究有限公司 | 一种药物组合物及其在制备治疗烫伤药物中的用途 |
WO2015051695A1 (zh) * | 2013-10-12 | 2015-04-16 | 烟台益诺依生物医药科技有限公司 | 一种药物组合物在制备治疗脓毒症和炎性肺损伤药物中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN1954812B (zh) | 2010-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0711134B1 (en) | Medicinal for protection from neurological damage | |
Horton et al. | Free radical scavengers prevent intestinal ischemia-reperfusion-mediated cardiac dysfunction | |
EP0501637A2 (en) | Use of L-2-oxothiazolidine-4-carboxylate alone or in combination with glutathione esters and/or amino acids in the treatment of reperfusion injury | |
US20050272724A1 (en) | Spin trapping pharmaceutical compositions and methods for use thereof | |
CN1954812B (zh) | 依达拉奉的新用途 | |
US7645733B2 (en) | Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions | |
Teicher et al. | RSR13: Effects on tumor oxygenation and response to therapy | |
WO2002085117A1 (en) | Methods and compositions for preventing and treating septic shock and endotoxemia | |
US20080292580A1 (en) | Treatment of Inflammatory Diseases | |
CN107137417A (zh) | 一种用于治疗恶病质的药物组合物及其应用 | |
JP4914344B2 (ja) | 虚血/再灌流障害治療用のアドレノメデュリン及びアドレノメデュリン結合タンパク質 | |
EP2106791A1 (en) | Glutamine or glutamine-containing dipeptide in a specific dosage for the treatment of inflammation | |
US7754247B2 (en) | Resuscitation fluid | |
CN111939122B (zh) | 肺动脉高压靶向治疗的速效制剂 | |
JP3587851B2 (ja) | Tnf誘発病状の治療におけるベンジダミンの使用 | |
KR101086040B1 (ko) | 간섬유화 및 간경화 치료 효과를 갖는 아시아트산 유도체 | |
Chen et al. | Beneficial effects of sanguisorbae radix in renal dysfunction caused by endotoxin in vivo | |
JPH08245403A (ja) | インシュリン抵抗性症候群治療用組成物 | |
RU2523792C1 (ru) | Лекарственное средство для лечения туберкулеза | |
JP2000514064A (ja) | 敗血症誘導性急性腎不全および腎血管収縮ならびにカテコールアミン誘導性腎および腸管膜血管収縮の治療 | |
IL308793A (en) | Safe delivery of an MMP-12 inhibitor | |
Kolieb et al. | Effect of Xanthenone Versus Irisin in Alleviating Renal Ischemic Reperfusion Injury through Modifying the PI3K/AKT/eNOS and TLR-4/NFkB Pathways | |
JPH08508710A (ja) | 新規処置方法 | |
CN112826820A (zh) | Nlrp3抑制剂及其应用 | |
CN101301307A (zh) | Dft在制备治疗和预防脓毒症药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20090515 Address after: 699-18, Xuanwu Avenue, Nanjing, Jiangsu Province, China: 210042 Applicant after: Jiangsu Sheng Sheng Pharmaceutical Research Co., Ltd. Co-applicant after: Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. Address before: Postal code 12, Huayuan Road, Jiangsu, Nanjing: 210042 Applicant before: Jiangsu Simcere Pharmaceutical Research Company Limited |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: NANJING SIMCERE DONGYUAN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: NANJING SIMCERE DONGYUAN PHARMACEUTICAL CO., LTD. |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 210042 NO.699-18, XUANWU AVENUE, NANJING CITY, JIANGSU PROVINCE TO: 210042 NO.12, HUAYUAN LIZHAN, NANJING CITY, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20101223 Address after: Nanjing City, Jiangsu province 210042 garden reached No. 12 Co-patentee after: Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. Patentee after: Jiangsu Simcere Pharmaceutical Research Company Limited Co-patentee after: Jilin Boda Pharmaceutical Co.,Ltd. Address before: 210042 Xuanwu Avenue, Jiangsu, Nanjing, China 699-18 Co-patentee before: Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. Patentee before: Jiangsu Simcere Pharmaceutical Research Company Limited |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160728 Address after: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18 Patentee after: Jiangsu Simcere Pharmaceutical Co., Ltd. Patentee after: Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. Patentee after: Jilin Boda Pharmaceutical Co.,Ltd. Address before: Nanjing City, Jiangsu province 210042 garden reached No. 12 Patentee before: Jiangsu Simcere Pharmaceutical Research Company Limited Patentee before: Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. Patentee before: Jilin Boda Pharmaceutical Co.,Ltd. |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18 Patentee after: Jiangsu Simcere Pharmaceutical Co., Ltd. Patentee after: Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. Patentee after: Jilin Boda pharmaceutical Limited by Share Ltd Address before: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18 Patentee before: Jiangsu Simcere Pharmaceutical Co., Ltd. Patentee before: Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. Patentee before: Jilin Boda Pharmaceutical Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 210042 -18, Xuanwu Avenue, Xuanwu District, Jiangsu, Nanjing, 699 Patentee after: JIANGSU SIMCERE PHARMACEUTICAL Co.,Ltd. Patentee after: SIMCERE PHARMACEUTICAL Group Patentee after: Jilin Boda pharmaceutical Limited by Share Ltd. Address before: 210042 -18, Xuanwu Avenue, Xuanwu District, Jiangsu, Nanjing, 699 Patentee before: JIANGSU SIMCERE PHARMACEUTICAL Co.,Ltd. Patentee before: NANJING SIMCERE DONGYUAN PHARMACEUTICA Co.,Ltd. Patentee before: Jilin Boda pharmaceutical Limited by Share Ltd. |
|
CP01 | Change in the name or title of a patent holder |